Atypical Proliferative (Borderline) Serous Tumor in the Brain: A Case Report.
Xing D, Jenson EG, Zwick CA, Rodriguez FJ, Kurman RJ.
Int J Gynecol Pathol. 2018 Jan;37(1):52-56. doi: 10.1097/PGP.0000000000000389.
Atypical meningiomas.
Chen R, Aghi MK.
Handb Clin Neurol. 2020;170:233-244. doi: 10.1016/B978-0-12-822198-3.00043-4.
Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation.
Martin M, Grisham RN, Turashvili G, Halpenny DF, Aghajanian CA, Makker V.
Gynecol Oncol Rep. 2017 Sep 6;22:9-12. doi: 10.1016/j.gore.2017.09.001. eCollection 2017 Nov.
Geographical variation in malignant and benign/borderline brain and CNS tumor incidence: a comparison between a high-income and a middle-income country.
Wanner M, Rohrmann S, Korol D, Shenglia N, Gigineishvili T, Gigineishvili D.
J Neurooncol. 2020 Sep;149(2):273-282. doi: 10.1007/s11060-020-03595-5. Epub 2020 Aug 19.
A Rare Case of Ovarian Serous Borderline Tumor with Brain Metastasis.
Veran-Taguibao S, Taguibao RAA, Gallegos N, Farzaneh T, Kim R, Lin F, Lu D.
Case Rep Pathol. 2019 May 22;2019:2954373. doi: 10.1155/2019/2954373. eCollection 2019.
Germline variants in tumor suppressor FBXW7 lead to impaired ubiquitination and a neurodevelopmental syndrome.
Stephenson SEM, Costain G, Blok LER, Silk MA, Nguyen TB, Dong X, Alhuzaimi DE, Dowling JJ, Walker S, Amburgey K, Hayeems RZ, Rodan LH, Schwartz MA, Picker J, Lynch SA, Gupta A, Rasmussen KJ, Schimmenti LA, Klee EW, Niu Z, Agre KE, Chilton I, Chung WK, Revah-Politi A, Au PYB, Griffith C, Racobaldo M, Raas-Rothschild A, Ben Zeev B, Barel O, Moutton S, Morice-Picard F, Carmignac V, Cornaton J, Marle N, Devinsky O, Stimach C, Wechsler SB, Hainline BE, Sapp K, Willems M, Bruel AL, Dias KR, Evans CA, Roscioli T, Sachdev R, Temple SEL, Zhu Y, Baker JJ, Scheffer IE, Gardiner FJ, Schneider AL, Muir AM, Mefford HC, Crunk A, Heise EM, Millan F, Monaghan KG, Person R, Rhodes L, Richards S, Wentzensen IM, Cogné B, Isidor B, Nizon M, Vincent M, Besnard T, Piton A, Marcelis C, Kato K, Koyama N, Ogi T, Goh ES, Richmond C, Amor DJ, Boyce JO, Morgan AT, Hildebrand MS, Kaspi A, Bahlo M, Friðriksdóttir R, Katrínardóttir H, Sulem P, Stefánsson K, Björnsson HT, Mandelstam S, Morleo M, Mariani M; TUDP Study Group; Scala M, Accogli A, Torella A, Capra V, Wallis M, Jansen S, Weisfisz Q, de Haan H, Sadedin S; Broad Center for Mendelian Genomics; Lim SC, White SM, Ascher DB, Schenck A, Lockhart PJ, Christod…
Am J Hum Genet. 2022 Apr 7;109(4):601-617. doi: 10.1016/j.ajhg.2022.03.002.
Single-cell transcriptomics identify TNFRSF1B as a novel T-cell exhaustion marker for ovarian cancer.
Gao Y, Shi H, Zhao H, Yao M, He Y, Jiang M, Li J, Li Z, Su S, Liu T, Yin C, Liao X, Yue W.
Clin Transl Med. 2023 Sep;13(9):e1416. doi: 10.1002/ctm2.1416.
The 2022 WHO classification of tumors of the pituitary gland: An update on aggressive and metastatic pituitary neuroendocrine tumors.
Casar-Borota O, Burman P, Lopes MB.
Brain Pathol. 2025 Jan;35(1):e13302. doi: 10.1111/bpa.13302. Epub 2024 Sep 1.
Heterogeneity of tumor immune microenvironment of EGFR/ALK-positive tumors versus EGFR/ALK-negative tumors in resected brain metastases from lung adenocarcinoma.
Xiao G, Li L, Tanzhu G, Liu Z, Gao X, Wan X, Xiao D, Chen L, Xia X, Zhou R.
J Immunother Cancer. 2023 Mar;11(3):e006243. doi: 10.1136/jitc-2022-006243.
Corrigendum to "Brain metastasis in advanced serous borderline tumor of the ovary: A case presentation" [Gynecol. Oncol. Rep. 22 (2017) 9-12].
Martin M, Grisham RN, Turashvili G, Halpenny DF, Aghajanian CA, Makker V.
Gynecol Oncol Rep. 2017 Sep 29;22:118. doi: 10.1016/j.gore.2017.09.014. eCollection 2017 Nov.
